AstraZeneca P.L.C. said today that a federal court granted the company's request for a temporary restraining order, barring Apotex Inc. from launching a generic version of its Pulmicort respules, which treat asthma. London-based AstraZeneca's U.S. headquarters are in Wilmington - Miriam Hill
